Skip to main content
. 2016 Apr 18;36:472–479. doi: 10.1007/s10875-016-0284-3

Table 4.

Ig route, trough levels, lung disease and co-morbidities for each patient

Patient number Ig route IgG trough level (g/dl)a Lung diseaseb Prophylactic antibiotics Co-morbidities
CT Lung function
1 IV 7.4 Not done Not done None Gastro-esophageal reflux
2 SC 7.1 Normal Not done None Eczema
3 SC 8.7 Progression Stable—obstructive None
4 IV 11.7 Stable disease Stable—obstructive Azithromycin 3×/week
5 SC 7.6 Stable disease Stable—obstructive None
6 SC 7.9 Normal Stable—normal None
7 SC 5.8 Progression Stable—restrictive None
8 SC 1.6 Stable disease Deterioration—obstructive None
9 IV 6.9 Normal Stable—normal None Deafness
10 SC 9.0 Normal Stable—normal None
11 IV 7.6 Normal Stable—normal None
12 SC 9.5 Normal Stable—normal Azithromycin 3×/week
13 IV 11.5 Progression (pre-transplant) Deterioration—obstructive
(pre-transplant)
Co-trimoxazole daily Lung transplant
14 IV 10.0 Progression Stable—normal None
15 IV 15.3 Progression Not done None Autism, epilepsy

aMean over the last 5 years

bFrom the previous 5 years